SCHEMBL22563487

SCHEMBL22563487

Cc1cc(C)c(-c2ccc3c4ccc(-c5c(C)cc(C)cc5C)cc4n(-c4cc(-c5nc(C)cc(C)n5)cc(-n5c6cc(-c7c(C)cc(C)cc7C)ccc6c6ccc(-c7c(C)cc(C)cc7C)cc65)c4C#N)c3c2)c(C)c1

nearest known ligand 0.31

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.31
ABL1 P00519 1/20 0.31
NPSR1 Q6W5P4 3/20 0.30
ALDH1A1 P00352 2/20 0.30
HPGD P15428 2/20 0.30
PPARG P37231 1/20 0.30
STAT3 P40763 1/20 0.30
RXFP1 Q9HBX9 1/20 0.30
NR2E3 Q9Y5X4 1/20 0.30
NCOR2 Q9Y618 1/20 0.30
KDM5B Q9UGL1 1/20 0.30
HSD17B10 Q99714 1/20 0.30
AURKA O14965 1/20 0.30
KDR P35968 1/20 0.30
AURKB Q96GD4 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22563484 0.95 PDE9A (0.34) KDM4ENPSR1ALDH1A1HPGDHSD17B10
SCHEMBL19942593 0.91 ABL1 (0.31) ABL1NPSR1KDM5B
SCHEMBL19909235 0.91 KDM5B (0.33) KDM4EABL1NPSR1ALDH1A1HPGD
SCHEMBL23487302 0.88 KDM5B (0.40) KDM4ENPSR1ALDH1A1HPGDPPARG
SCHEMBL23487305 0.87 NPSR1 (0.37) KDM4ENPSR1ALDH1A1HPGDPPARG
SCHEMBL23487671 0.87 ABL1 (0.34) KDM4EABL1NPSR1ALDH1A1HPGD
SCHEMBL19942591 0.86 PDE9A (0.34) KDM4ENPSR1ALDH1A1HPGDHSD17B10
SCHEMBL21279145 0.86 ALDH1A1 (0.33) KDM4ENPSR1ALDH1A1HPGDPPARG
SCHEMBL19909228 0.86 PDE9A (0.35) KDM4ENPSR1ALDH1A1HPGDKDM5B
SCHEMBL22563686 0.86 NPSR1 (0.34) KDM4ENPSR1ALDH1A1HPGDPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210175434-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2021-06-10 US disclosed
EP-3580300-B1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-10-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210175434-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, OR51E2, OCIAD2 KDM4E 4619/4885ABL1 2208/4885NPSR1 1484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.